Atom Grants
Toggle Sidebar main
Eligibility
Profile
Finance
Other
Similar Grants
Platform
Discover
For You
Search
Favorites
Account
Profile
Research Interests
Atom | Cell and Gene Therapy (CGT) Access Model
Back
Cell and Gene Therapy (CGT) Access Model
Due: Mar 14, 2025
HHS-CMS
$9,550,000
Description
This Notice of Funding Opportunity (NOFO) announces the opportunity to apply for Cooperative Agreement funding to support States participation in the Cell and Gene Therapy (CGT) Access Model (the CGT Access Model or the Model). Eligible applicants are States, the District of Columbia, and any U.S. territory that participates in the Medicaid Drug Rebate Program (MDRP). A maximum of $9.55 million may be awarded to each Recipient, depending on the number of States that apply for funding, pending availability of funds.
Estimated Total Program Funding
$95,500,000
Expected Number of Awards
52
Award Ceiling
$9,550,000
Eligible Applicants
- State governments
- Others
Additional Eligibility Information
Eligible applicants are States, the District of Columbia, and any U.S. Territory participating in the Medicaid Drug Rebate Program (MDRP).
Funding Type
Cooperative Agreement
Categories of Funding Activity
- Health
Opportunity Type
Discretionary
Grantor Contact Information
Grants.gov Customer Support
Grantor Email
support@grants.gov
Other Grantor Information
Grants.gov Contact Center <br/>Phone Number: 1-800-518-4726 <br/> <br/>Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays. <br/>support@grants.gov
Additional Information
Cell and Gene Therapy (CGT) Access Model
Supporting Link
https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=110782
Start finding grants with Atom for
$0 today
$30 Billed monthly after 7-day trial. Cancel anytime.
Personalized grant emails delivered weekly, right to your inbox.
AI powered search engine with both keyword and semantic search capabilities.
Grant filters to find the perfect funding opportunities.
Get Started
Similar Grants
Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
Due: Feb 13, 2026
HHS-NIH11
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Due: Oct 19, 2027
HHS-NIH11
$650,000
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Due: Oct 12, 2121
HHS-NIH11